The Efficacy of Serum Biomarkers and Ultrasound Parameters in Prediction of Outcome in Threatened Abortion | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 1, Volume 76, Issue 4, July 2019, Pages 3835-3839 PDF (420 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2019.41523 | ||
| Authors | ||
| Hanaa Omer Badr El Dien; Asmaa Mahmoud Abd Elwahab; Eman Mostafa Abdalla* | ||
| Department of Obstetrics and Gynecology, of Medicine, Al-Azhar University | ||
| Abstract | ||
| Background: miscarriage, also known as a spontaneous loss of pregnancy before the fetus reaches viability. Objectives: the aim of this study is to evaluate the association between ultrasonographic findings and maternal serum biomarkers levels and prediction of pregnancy outcome in threatened miscarriage. Patients and Methods: a prospective observational study was conducted at Al-Zahraa University Hospital through the period from April 2018 to May 2019 involving 76 women in their first trimester threatened abortion. Results: there was a statistically significant difference between group 1 and group 2 regarding cancer antigen (CA) 125, β-hCG, progesterone, yolk sac diameter (YSD), fetal heart rate (FHR) and crown-rump length (CRL). The sensitivity, specificity, PPV and NPV of CA 125 at 37.2 IU/ml were 86.0, 84.3, 84.6 and 85.7, respectively, for β-hCG at 19447 IU/ml were 80.6, 78.0, 78.4 and 79.8, respectively, for progesterone at 12.3 ng/ml were 90.1, 88.0, 88.2 and 89.8, respectively, and for FHR at 122 b pm were 96.1, 94.1 respectively. Conclusion: combining of measurement of serum progesterone at a level of 12.3 ng/ml to FHR at 122 bpm represent noninvasive, early, fast and excellent predictor of pregnancy outcome in women with threatened abortion. | ||
| Keywords | ||
| CA125; β-hCG, Progesterone; Fetal heart rate, CRL, GSD, YSD, Threatened abortion | ||
|
Statistics Article View: 468 PDF Download: 677 |
||
